abstract |
1,2,4-triaminobenzene derivatives of formula (I) and pharmaceutically acceptable salts thereof that are openers of the KCNQ family potassium channels are disclosed, wherein the variables are as defined in the specification. These compounds are useful for the prevention, treatment and/or inhibition of disorders of the central nervous system |